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ABSTRACT 
During colonization, enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) 
Escherichia coli are capable to manipulate host cytoskeleton and colonize gut 
epithelia by a specific mode of attachment known as the attaching and effacing 
lesion (A/E lesion). While actin rearrangements during A/E lesion formation have 
been  extensively  investigated,  the  possible  alterations  of  other  cytoskeletal 
elements  like  those  comprising  the  intercellular  junctional  complexes  (JC)  of 
polarized cells during infection have only lately attracted attention. The present 
mini-review addresses the opposite effects of two groups of bacteria, A/E lesion-
forming pathogenic E. coli and probiotic bacterial strains, on JC. JC are important 
in maintaining gut barrier functions. EPEC and EHEC can disrupt JC which as a 
consequence leads to reduction in the transepitelial electrical resistance (TER) 
and an increase of the permeability to macromolecules. Probiotic bacteria on the 
other  hand  stabilize  JC  thus  increasing  TER  and  reducing  permeability  to 
macromolecular markers. Probiotic strains can protect JC integrity of polarized 
cells from the damage caused by EPEC or EHEC. Together with the promise of 
these results, of concern is the fact that the outcome of the studies can differ 
dependent on experimental protocols. Studies with living bacteria and different 
strain combinations have also put forward strain specific effects. Therefore, an 
important practical item for future studies is the identification of the molecules 
synthesized by probiotic bacteria that may be active on JC stability.  
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Introduction 
Enteropathogenic  and  enterohaemorrhagic  Escherichia 
coli  (resp.,  EPEC  and  EHEC)  are  adapted  to  colonize  gut 
epithelia  by  a  specific  mode  of  attachment  known  as 
attaching and effacing lesion (A/E lesion). This is produced 
due  to  the  capacity  of  A/E  pathogens  to  manipulate  host 
cytoskeleton. Using their Type III secretion machinery, the 
bacteria inject into the eukaryotic cell a translocated intimin 
receptor  (Tir).  Tir  is  then  integrated  in  the  host  cell 
membrane and interacts with intimin molecules available at 
the bacterial surface thus enforcing the pathogen’s adherence. 
Epithelial microvilli in such loci lose their typical structure 
and  form  pedestals  where  actin  accumulates  under  the 
elevated cell membrane (Frankel & Philips, 2008).  
This type of lesion has been known for decades, and the 
molecular  mechanisms  by  which  EPEC  and  EHEC 
manipulate  the  host-cell  actin  cytoskeleton  have  been 
extensively examined. Meanwhile the putative alterations of 
other  cytoskeletal  components  have  been  more  or  less 
neglected.  
One of the basic disease symptoms that accompany EPEC 
and EHEC infections is diarrhea. An important pathogenic 
phenomenon  related  with  diarrhea  is  the  damage  of  the 
barrier  functions  of  the  intestine  leading  to  uncontrolled 
influx  of  water  and  solutes.  These  barrier  functions  in  the 
healthy intestine are maintained due to the integrity of the 
epithelial  junctional  complexes  (JC).  Nevertheless,  it  was 
only lately that the effects of EPEC and EHEC on JC have 
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As an opposite, recent studies have shown the beneficial 
effects  of  probiotic  bacteria on  JC  integrity.  The  present 
review will focus on the mode of JC damage by A/E lesion-
forming E. coli and the promise of the probiotic application 
against this. 
Junctional  complexes  and  epithelial  barrier 
damage by A/E pathogens  
Interaction of A/E bacteria with the polarized (epithelial) 
host cells is accompanied by a complex set of events related 
to  cytoskeleton  rearrangement  and  impairment  of  the 
epithelial barrier function. The epithelial barrier function is 
maintained  by  two  large  membrane  domains  (apical  and 
basolateral), the junctional complex between adjacent cells, 
composed of the tight junction (TJ), adherens junction (AJ), 
and desmosomes (D). Bundles of actin filaments support the 
subapical  membrane  and  some  specialized  membrane 
structures  such  as  microvilli  and  junctional  complexes  (TJ 
and AJ).  
The  main  cellular  structure  that  maintains  cell  polarity 
and does not allow lateral diffusion of apical proteins as well 
as pericellular permeability of large soluble molecules is the 
tight junction. Tight junctions are composed of a branching 
network of transmembrane proteins (claudins and occludins) 
embedded  in  both  contact  membranes,  with  extracellular 
domains  joining  to  one  another.  The  cytoplasmic  actin 
directly interacts with claudins and with the zonula occludens 
(ZO)  family  of  cytoplasmic  proteins  (Delorme-Axford  & 
Coyne,  2011).  ZO-1  binds  numerous  transmembrane  and 
cytoplasmic proteins and is required for the assembly of both 
adherens  and  tight  junctions.  Depletion  of  ZO-1  leads  to 
reversible loss of junctional integrity and barrier function and 
alterations in transepithelial permeability (Van Itallie et al., 
2009; Yu et al., 2010).  
Another  junction,  important  for  epithelial  integrity 
sustaining, localized near the TJ, is the adherens junction 
(AJ).  The  adhesive  properties  of  AJ  are  determined  by 
specialized  integral  membrane  proteins  comprising  the 
protein family of cadherins. E-cadherin is a protein specific 
for  epithelial  cells,  and  is  functionally  linked  to  the 
generation  of  a  polarized  epithelial  phenotype.  The 
extracellular  region  of  this  protein  binds  to  cadherins  of 
adjacent  cells  and  the  intracellular  regions  of  e-cadherins 
interact  with  cytoplasmic  actin  by  catenins  and  other 
regulatory proteins (Tian et al., 2011). In vitro studies have 
shown  that  E-cadherin  is  not  only  necessary  for  adherens 
junction formation but is also essential for the assembly of 
other  junctional  complexes  such  as  desmosomes,  gap 
junctions and tight junctions (Tunggal et al., 2005).  
During  certain  disease  states,  including  viral  or  A/E 
pathogens infection, the ability of the intestinal epithelium to 
regulate  absorption  and  secretion  is  severely  disturbed, 
resulting in diarrhea (Shifflett et al., 2005; Delorme-Axford 
& Coyne, 2011). Despite the advances made in understanding 
of EPEC and EHEC pathogenesis at the molecular level, how 
the infection triggers diarrhea is still unclear. Both EPEC and 
EHEC  alter  intestinal  epithelial  barrier  function  by  TJ 
disruption and loss of interaction of the transmembrane TJ 
proteins  occludin  and  claudin-1  with  the  cytosolic  plaque 
protein ZO-1, which links them to cortical F-actin (Hanajima-
Ozawa  et  al,  2007).  EHEC  lower  transepithelial  electric 
resistance (TER), increase the paracellular flux of mannitol, 
and  alter  ZO-1  distribution  by  the  signaling  pathways 
including myosin light chain kinase and conventional protein 
kinase C (PKC) (Philpott et al., 1998; Berkes et al., 2003). In 
contrast, conventional PKCs do not appear to participate in 
the EPEC-associated disruption of TJs (Berkes et al., 2003). 
In  vitro  studies  have  demonstrated  that  the  EPEC  effector 
protein  EspF  plays  a  central  role  in  decreasing  TER  and 
altering  the  intestinal  epithelial  TJ  structure.  Specifically, 
EPEC induce disruption of TJ architecture as evidenced by a 
loss of TJ protein–protein interactions, redistribution of  TJ 
proteins,  and  the  appearance  of  aberrant  TJ  strands  in  the 
lateral membrane (Shifflett et al., 2005; Hanajima-Ozawa et 
al, 2007). Surprisingly, recruitment of  ZO-1 only does  not 
lead to the loss of TER hence other proteins may be involved 
in these pathological conditions. The knockout of  ZO-1 in 
mouse epithelial cells causes a pronounced delay in junction 
assembly, but has no effect on already mature junctions so 
apparently ZO-1 is not essential for tight junction formation 
(McNeil et al., 2006).  
In a recent study on in vivo effect of EHEC infection on 
murine  intestinal  barrier  function,  no  alterations  of  ZO-1 
distribution  was  detected,  but  reduction  of  TER, 
redistribution  of  occludin  and  claudin-3  and  increased 
expression of claudin-2 was observed in the colon of infected 
mice  5-10  days  after  infection  (Roxas  et  al.,  2010). These 
controversial results need more comprehensive studies on the 
molecular mechanisms of infection-induced JC alterations.  
An  important  factor  known  to  regulate  epithelial 
monolayer  permeability  and  TJ  stability  is  the  adherens 
junction, composed mainly of the transmembrane protein E-
cadherin and cytosolic catenins. It has been shown that EPEC 
infection  induces  significant  changes  in  the  adherens ISSN: 1314-6246  Topouzova et al.  J. BioSci. Biotech. 2012, 1(2): 83-89. 
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junctions of Caco-2 monolayers, accompanied by significant 
phosphorylation of PKC-α associated with cadherins, leading 
to  the  dissociation  of  the  cadherin/beta-catenin  complex 
(Malladi  et  al.,  2004).  Some  pathogenic  bacteria,  such  as 
enteropathogenic  Escherichia  coli,  Shigella  flexneri,  and 
Campylobacter  jejuni,  cleaved  E-cadherin  of  host  cells  to 
disrupt  the  epithelial  barrier,  but  it  remained  unknown 
whether this maybe a general virulence mechanism (Hoy et 
al., 2012). 
Probiotic  bacteria  can  counteract  A/E  lesion-
forming  pathogenic  bacteria  by  stabilizing 
junctional  complexes  and  epithelial  barrier 
function 
According  to  the  FAO/WHO  definition,  probiotics  are 
live  non-pathogenic  microorganisms  that  have  beneficial 
effects on human health: 
http://www.fao.org/es/esn/food/foodandfood_probio_en.stm 
The mechanisms by which different probiotics achieve this 
are  variable,  numerous  and  are  beyond  the  scope  of  this 
review.  
Lately, the capacity of live probiotic bacteria to promote 
gut  barrier  function  has  been  the  scope  of  an  increased 
number of studies and the focus of several reviews (Liévin-
Le Moal & Servin, 2006; Walter, 2008; Guttman & Finlay, 
2009; Lutgendorff et al., 2009.; Kim et al., 2010; Ohland & 
MacNaughton,  2010;  Ahrne  et  al.,  2011;  Gill  et  al., 2011; 
Ulluwishewa  et  al.,  2011).  Using  in  vitro  models  of  cell 
culture  monolayers,  probiotic  strains  have  been  shown  to 
increase  TER,  reduce  permeability  to  macromolecules  and 
stimulate the expression of JC proteins. This was monitored 
in  various  experiments  by  TER  measurements,  Western 
blotting,  qRT-PCR  and  microarray  techniques.  On  the 
cellular level, the probiotic bacteia when applied alone have 
been shown to promote the synthesis of JC components by 
the cultured cells. This kind of stabilization, in particular that 
of the TJ, could be a most probable reason for maintaining 
TER  and  permeability  values  even  after  prolonged  co-
cultivation  with  cell  cultures  in  the  absence  of  antibiotics. 
Table 1. provides several examples on the mechanisms of the 
action  of  probiotic  bacteria:  Lactobacillus  plantarum,  L. 
rhamnosus, L. casei and E. coli Nissle 1917, on cultured-cell 
monolayers.  
These effects further proved beneficial in the presence of 
diarrheagenic  E.  coli  from  several  pathotypes  (Table  1). 
Importantly, in the strain and dose combinations used in the 
cited  studies,  the  probiotic  bacteria  had  no  antibacterial 
activity  against  the  pathogens.  Hence  the  effects  on  JC 
stability  can  be  considered  as  pivotal  for  the  observed 
outputs.  While  very  promising,  these  data  are  nevertheless 
not easy to compare with one another due to the variety of 
applied experimental protocols (Table 1). Bacteria in the test 
systems  were  used  in  different  amounts  and  proportions. 
Some data imply that pre-treatment with the probiotic strain 
was decisive for the beneficial effect (Sherman et al., 2005; 
Johnson-Henry et al., 2008). In other cases, co-cultivation of 
the strains was performed (Qin et al., 2009; Liu et al., 2010, 
Zyrek  et  al.,  2007).  Only  a  few  data  have  shown  that  the 
probiotic,  if  applied  after  the  EPEC,  can  result  in  some 
restoration of TER values and reduction of the JC damage 
(Parassol  et  al.,  2005).  And  finally,  strain-specific  effects 
have to be underlined as well, and this concerns both the E. 
coli and the probiotic strains (Stöber et al., 2010).  
In  vivo  evidence  for  effects  of  probiotic  bacteria  on 
uninfected  or  infected  animal  models  are  even  sparser.  In 
rats,  L.  acidophilus  has  been  shown  to  increase  occludin 
expression and maintain gut epithelial tight junctions (Qin et 
al.,  2005).  In  germfree  mice,  L.  reuteri  ATCC  PTA  6475 
protected the animals from disease manifestation caused by 
EHEC (Eaton et al., 2011). 
Metabolic products and molecular mechanisms 
related with the effects of probiotic bacteria and 
A/E lesion-forming pathogens on epithelial JC: 
questions and perspectives 
How do these in vitro results rely to situations of heavy 
infectious diarrheas?  
Together  with  strain-specific  differences,  when  the 
application  of  live  probiotic  bacteria  is  considered  usually 
time is needed to settle the correct type of ecosystem that will 
ensure  the  probiotic’  benefits.  Unfortunately,  in  infections 
with  A/E  lesion-forming  pathogens  there  is  rarely  a  lot  of 
time  available.  A/E  infections  are  acute,  and  especially  in 
cases of Shiga toxin- producing strains there is a high risk. 
Antibiotics are undesirable since  massive death of bacteria 
will  result  in  release  of  high  amounts  of  toxins  thus 
increasing greatly the danger for the patient. Prospects were 
sought in the application of bacteriophages, bacteriocins, and 
low  molecular-weight  inhibitors,  but  for  the  time  being  in 
trials none of the interventions proved superior to supportive ISSN: 1314-6246  Topouzova et al.  J. BioSci. Biotech. 2012, 1(2): 83-89. 
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therapy alone (Muniesa et al., 2012). 
Provided the beneficial effects of probiotic strains on JC 
stability and epithelial barrier function, one reasonable task 
would be the identification of the molecules responsible for 
these effects. Such molecules may prove useful in therapy by 
themselves, without the need to apply the live probiotics and 
wait for the ecosystem to settle.  
To check for JS-stabilizing activity of released products, 
cell-free  supernatants  of  probiotic  bacteria  were  applied  to 
cultured  cells.  It  was  shown  that  cell-free  supernatant  of 
Bifidobacterium  lactis  and  B.  infantis  reduced  TER  and 
prevented  the  EHEC-induced  damage  of  tight  junctions 
(Ewaschuk et al., 2008; Putaala et al., 2008). Apart from the 
stabilization of epithelia, released products (total supernatants 
and selected fractions from them) from L. acidophilus La-5 
and L. reuteri ATCC 55730 were shown to influence EHEC 
virulence  by  reducing  extracellular  concentrations  of 
autoinducer-2  and  suppressing  quorum  sensing-regulated 
expression of virulence-related genes (Medellin-Peña et al., 
2007; Jelčić et al., 2008; Medellin-Peña & Griffiths, 2009). 
Still of concern, when working with spent culture media from 
probiotic  strains  there  remains  the  possibility  of  strain-
specific responses of the A/E-forming pathogens.  
The promise in these types of studies is the expectation 
for  a  further  more  precise  identification  of  the  molecules 
responsible for JC stabilization.  
One  group  of  such  molecules  that  lately  attracted 
attention  is  the  surface  proteins  of  lactobacilli.  Thus,  the 
surface  layer  adhesive  protein  (SLAP)  from  L.  plantarum 
CGMCC  1258,  while  inhibiting  EPEC  adhesion  to  Caco-2 
cells, stimulated the expression of TJ- associated proteins and 
promoted  the  maintenance  of  TER  and  TJ  structure,  the 
levels of extracellular signal-regulated kinase (EPK) and EPK 
phosphorylation (Liu et al., 2011b).  
Another  surface  protein  in  focus  is  the  micro  integral 
membrane  protein  (MIMP)  from  L.  plantarum  CGMCC 
1258.  NCM460  cells  transiently  infected  with  MIMP  are 
characterized  by  increased  synthesis  of  the  TJ  protein 
claudin-1 by NCM460 cells. Together with this the protein 
reduced the attachment of EPEC to the cultured cells (Liu et 
al., 2011a). 
Conclusion 
While  still  quite  new,  the  studies  on  the  interactions 
between A/E lesion-forming bacteria, probiotic bacteria and 
epithelial  junctional  complexes,  due  to  the  promise  for 
practical  applications,  put  in  focus  the  need  of  extensive 
studies, including more strain combinations, culture cell lines 
and in vivo models. For the time being, we have already some 
clarity  on  the  cellular  targets  (e.g.,  the  opposite  action  of 
probiotic bacteria and A/E lesion forming bacteria on JC and 
their components). Yet, by measuring the effects on TER, or 
JC  molecules  amounts  or  expression,  we  still  address  the 
output and not the mechanisms. And these seem to be the 
correct address for future work. 
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